Ultimate Prostate™

Ultimate Prostate™

  • $77.99



Helps reduce difficulty in urination

NPN 80038374

The Ultimate line is about improving lives, one body at a time, by correcting and maintaining metabolism and hormone balance as well as providing stress and immune support. Effective nutrient supplementation can often be the missing piece to optimal health. Our supplements are carefully formulated to provide the Ultimate in abundant energy, metabolism, health, and longevity.

Product summary

Ultimate Prostate contains a comprehensive blend of plant extracts and nutrients to support healthy prostate tissue and function. As part of an overall commitment to prostate health, it offers a natural solution for on-going prostate problems such as difficulty in urination associated with the early symptoms of benign prostatic hyperplasia (BPH).


  • Supports prostate health
  • Reduces symptoms of BPH
  • Helps reduce difficultly in urination associated with early symptoms of BPH
  • Improves urinary flow
  • Reduces frequent nighttime urination
  • Contains factors for the maintenance of good health

Research Benign prostatic hyperplasia (BPH), defined as the enlargement or swelling of the prostate gland, is one of the most common health problems faced by men. Over 50% of men age 50 and over suffer from BPH, and almost 100% of men over the age of 80 can expect to develop this condition. (1) Prostate enlargement and symptoms of BPH are influenced by hormonal, inflammatory, and nutritional factors. (1)

Androgens (male hormones) play a critical role in the development of BPH. Specifically, dihydrotestosterone (DHT), the active metabolite of testosterone, causes the prostate gland to enlarge. (1) Beta-sitosterol is a plant sterol that supports healthy prostate function. It works by inhibiting the enzyme 5-alpha reductase that is responsible for converting testosterone to DHT. (2) A six-month placebo-controlled trial of men with BPH found that supplementation with 130 mg of beta-sitosterol per day significantly improved international prostate symptom scores (IPSS) by 51%, compared with only 19% for the placebo. Supplementation also improved measures of quality of life, peak urinary flow rate, and post-void residual urinary volume. (3)

Pygeum (Pygeum africanum) bark and stinging nettle (Urtica dioica) root extracts are additional sources of beta-sitosterol that have been used successfully to reduce symptoms of BPH, such as weak urine flow and incomplete voiding of urine. (2,4) A review of 18 controlled clinical trials found that men taking Pygeum extract were more than twice as likely as placebo groups to experience improved BPH symptoms. Overall, the studies found that Pygeum reduced nocturia by 19%, reduced residual urine volume by 24%, and increased peak urine flow by 23%. (5)

A six-month placebo-controlled trial found that 81% of BPH patients who were supplemented with 360 mg of stinging nettle extract per day had improved lower urinary tract symptoms compared to 16% of the placebo group. Patients experienced a 77% improvement in peak urine flow rates and a modest reduction in prostate size. (4)

Vitamin D3 intake is positively associated with a lower rate of BPH because of its role in inhibiting the hormonal aspects of its development. Preclinical trials have demonstrated that supplementation with vitamin D3 can also help decrease existing BPH cell growth. (6)

Inflammation contributes to the development of BPH and at chronic levels may progress BPH to the stage of disease. (1) Ultimate Prostate combines multiple antioxidant and anti-inflammatory ingredients, including lycopene, selenium, rosemary extract, and rye pollen. (2) Carnosol and carnosic acid, the main antioxidant compounds in rosemary, have been demonstrated through animal studies to provide an anticarcinogenic influence on prostate cells. (7)

Pollen extract is a mixture of natural anti-inflammatory compounds that inhibit the synthesis of signalling molecules and mediators of inflammation. Supplementation has been shown to improve quality of life and reduce pain in patients affected by chronic pelvic pain syndrome and chronic prostate inflammation. (2)

Eating a diet rich in fruits and vegetables provides the nutrients lycopene and zinc, which are critical to protecting overall prostate health. (2) Cruciferous vegetables, such as broccoli, are particularly important sources of the anti-carcinogenic compounds indole3-carbinol and sulforaphane, which help protect against prostate disease. (8)

BioPerine® black pepper extract is standardized to 95% piperine, an active alkaloid that improves the bioavailability of nutrients that may otherwise be difficult to absorb. (9)


Each capsule contains:

Vegapure FS Phytosterols (Glycine max) (45% beta-sitosterol) 100 mg
Stinging Nettle Extract 10:1 (Urtica dioica) (root) 83 mg
Rye Grass Extract 20:1 (Secale cereale) (pollen) 42 mg
Pygeum Extract (Pygeum africanum) (13% phytosterols) (bark) 33 mg
Indole-3-Carbinol 25 mg
Broccoli Powder (Brassica oleracea) (0.1% sulforaphane) (floret and stalk) 16.7 mg
Lycopene (Lycopersicon esculentum) (fruit) 3.3 mg
Zinc (amino acid chelate) (from Zinc Aminomin™) 3.3 mg
BioPerine® Black Pepper Extract (Piper nigrum) (95% piperine) (fruit) 0.83 mg
Rosemary Extract (Rosmarinus officinalis) (6% carnosic acid) (leaf) 33 mcg
Selenium (selenomethionine) 33 mcg
Vitamin D3 (cholecalciferol) 132 IU (3.3 mcg)

Non-medicinal ingredients: Microcrystalline cellulose, vegetarian capsule (cellulose, purified water), vegetable-grade magnesium stearate (lubricant), silica.

Recommended adult dose: 2 capsules 3 times daily with food, a few hours before or after taking other medications, or as directed by a health care practitioner. Consult a health care practitioner for use beyond 3 months.


Caution: Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking any other medications or natural health products, have a history of non-melanoma skin cancer, have or are predisposed to cancer, or have a liver disorder or develop liver-related symptoms (e.g., abdominal pain, jaundice, dark urine), or to exclude the diagnosis of prostate cancer. Zinc supplementation can cause a copper deficiency; do not take this product if you have a copper deficiency. Discontinue treatment and consult a health care practitioner if symptoms of diarrhea, constipation, dizziness, gastric pain, visual disturbances, unsteadiness, nausea, tremor, imbalance, irritable bowel, skin rash, or headaches appear. Discontinue use if you experience joint pain. Keep out of reach of children.

This product does not contain artificial preservatives, colours, or sweeteners; no dairy, sugar, wheat, gluten, yeast, egg, fish, shellfish, salt, tree nuts, or GMOs. Suitable for vegetarians.


1. Vuichoud, C., & Loughlin, K.R. (2015). Benign prostatic hyperplasia: epidemiology, economics and evaluation. Canadian Journal of Urology, 22 (Suppl 1), 1-6.

2. Cicero, A.F.G., Allkanjari, O., Busetto, G.M., et al. (2019). Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer. Archivio Italiano di Urologia e Andrologia, 91(3).

3. Klippel, K.F., Hiltl, D.M., Schipp, B., et al. (1997). A multicentric, placebo-controlled, double-blind clinical trial of b-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. BJU International, 80(3), 427-432.

4. Safarinejad, M.R. (2005). Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study. Journal of Herbal Pharmacotherapy, 5(4), 1-11.

5. Wilt, T.J., Ishani, A., MacDonald, R. et al. (2002). Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Systematic Review, (1), CD001044.

6. Espinosa, G., Esposito, R., Kazzazi, A., et al. (2013). Vitamin D and benign prostatic hyperplasia—a review. Canadian Journal of Urology, 20(4), 6820-6825.

7. Petiwala, S.M., Puthenveetil, A.G, & Johnson, J.J. (2013). Polyphenols from the Mediterranean herb rosemary (Rosmarinus officinalis) for prostate cancer. Frontiers in Pharmacology, 4, 29.

8. Frydoonfar, H.R., McGrath, D.R., & Spigelman, A.D. (2003). The effect of indole-3-carbinol and sulforaphane on a prostate cancer cell line. ANZ Journal of Surgery, 73(3), 154-156.

9. Sing, A., & Duggal, S. (2009). Piperine – Review of advances in pharmacology. International Journal of Pharmaceutical Sciences and Nanotechnology, 2(3), 615-620.